Evidence map›Paper›PMID 29033585›Full record

ArticleOncoTargets and therapy2017

Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT.

Yijie Huang, Yexi Chen, Xiaoqi Lin, Qingjun Lin, Ming Han, Guohu Guo

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Silencing of SLP-2 inhibits the migration and invasion of cervical cancer cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yijie Huang *Department of General Surgery, Guangdong General Hospital, Guangzhou.
Yexi Chen *Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Xiaoqi LinDepartment of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Qingjun LinDepartment of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Ming HanDepartment of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Guohu GuoDepartment of General Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Shantou University · CNSecond Affiliated Hospital of Shantou University Medical College · CNGuangdong General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stomatin-like protein 2 (

Indexed as

epithelial–mesenchymal transitionhepatocellular carcinomamigrationprognosisproliferationstomatin-like protein 2

Identifiers

PMID29033585
PMCPMC5614784
OpenAlexW2755424481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.